Moriyama S - Search Results

1

Genetic profiling of thymic carcinoma using targeted next-generation sequencing.

Shitara M, Okuda K, Suzuki A, Tatematsu T, Hikosaka Y, Moriyama S, Sasaki H, Fujii Y, Yano M. Shitara M, et al. Among authors: moriyama s. Lung Cancer. 2014 Nov;86(2):174-9. doi: 10.1016/j.lungcan.2014.08.020. Epub 2014 Sep 10. Lung Cancer. 2014. PMID: 25249426

2

Expression of the MTA1 mRNA in advanced lung cancer.

Sasaki H, Moriyama S, Nakashima Y, Kobayashi Y, Yukiue H, Kaji M, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y. Sasaki H, et al. Among authors: moriyama s. Lung Cancer. 2002 Feb;35(2):149-54. doi: 10.1016/s0169-5002(01)00329-4. Lung Cancer. 2002. PMID: 11804687

3

Beta IGH3, a TGF-beta inducible gene, is overexpressed in lung cancer.

Sasaki H, Kobayashi Y, Nakashima Y, Moriyama S, Yukiue H, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y. Sasaki H, et al. Among authors: moriyama s. Jpn J Clin Oncol. 2002 Mar;32(3):85-9. doi: 10.1093/jjco/hyf021. Jpn J Clin Oncol. 2002. PMID: 11956302

4

Ratio of expression of p16INK4a to p14ARF correlates with the progression of non-small cell lung cancer.

Moriyama S, Nakashima Y, Yano M, Kaji M, Yamakawa Y, Toyama T, Yamashita H, Iwase H, Sasaki H, Saito Y, Kiriyama M, Kato J, Fujii Y. Moriyama S, et al. Jpn J Cancer Res. 2002 Jul;93(7):783-8. doi: 10.1111/j.1349-7006.2002.tb01320.x. Jpn J Cancer Res. 2002. PMID: 12149144 Free PMC article.

5

Gelatinolytic activity of matrix metalloproteinase in lung cancer studied using film in situ zymography stamp method.

Kaji M, Moriyama S, Sasaki H, Saitoh Y, Kiriyama M, Fukai I, Yamakawa Y, Mitsui A, Toyama T, Nemori R, Fujii Y. Kaji M, et al. Among authors: moriyama s. Lung Cancer. 2003 Feb;39(2):125-30. doi: 10.1016/s0169-5002(02)00453-1. Lung Cancer. 2003. PMID: 12581563

6

Cten mRNA expression was correlated with tumor progression in lung cancers.

Sasaki H, Moriyama S, Mizuno K, Yukiue H, Konishi A, Yano M, Kaji M, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y. Sasaki H, et al. Among authors: moriyama s. Lung Cancer. 2003 May;40(2):151-5. doi: 10.1016/s0169-5002(03)00037-0. Lung Cancer. 2003. PMID: 12711115

7

Decreased Hrad6B expression in lung cancer.

Sasaki H, Moriyama S, Nakashima Y, Yukiue H, Fukai I, Fujii Y. Sasaki H, et al. Among authors: moriyama s. Acta Oncol. 2004;43(6):585-9. doi: 10.1080/02841860410014920. Acta Oncol. 2004. PMID: 15370617

8

Histone deacetylase 1 mRNA expression in lung cancer.

Sasaki H, Moriyama S, Nakashima Y, Kobayashi Y, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y. Sasaki H, et al. Among authors: moriyama s. Lung Cancer. 2004 Nov;46(2):171-8. doi: 10.1016/j.lungcan.2004.03.021. Lung Cancer. 2004. PMID: 15474665

9

MEK1 and AKT2 mutations in Japanese lung cancer.

Sasaki H, Hikosaka Y, Kawano O, Moriyama S, Yano M, Fujii Y. Sasaki H, et al. Among authors: moriyama s. J Thorac Oncol. 2010 May;5(5):597-600. doi: 10.1097/JTO.0b013e3181d35236. J Thorac Oncol. 2010. PMID: 20354455 Free article.

10

Preservation of phrenic nerve involved by stage III thymoma.

Yano M, Sasaki H, Moriyama S, Kawano O, Hikosaka Y, Masaoka A, Fujii Y. Yano M, et al. Among authors: moriyama s. Ann Thorac Surg. 2010 May;89(5):1612-9. doi: 10.1016/j.athoracsur.2010.01.057. Ann Thorac Surg. 2010. PMID: 20417788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

637 results

Search Page

Filters